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Abstract
Human induced pluripotent stem cells (iPSCs) are reprogrammed by transient expression of transcription factors in somatic
cells. Approximately 1% of somatic cells can be reprogrammed into iPSCs, while the remaining somatic cells are
differentially reprogrammed. Here, we established induced pluripotent cancer stem-like cells (iCSCs) as self-renewing
pluripotent cell clones. Stable iCSC lines were established from unstable induced epithelial stem cell (iESC) lines through re-
plating followed by embryoid body formation and serial transplantation. iCSCs shared the expression of pluripotent marker
genes with iPSCs, except for REX1 and LIN28, while exhibited the expression of somatic marker genes EMP1 and PPARc. iESCs
and iCSCs could generate teratomas with high efficiency by implantation into immunodeficient mice. The second iCSCs
isolated from dissociated cells of teratoma from the first iCSCs were stably maintained, showing a gene expression profile
similar to the first iCSCs. In the first and second iCSCs, transgene-derived Oct4, Sox2, Klf4, and c-Myc were expressed.
Comparative global gene expression analyses demonstrated that the first iCSCs were similar to iESCs, and clearly different
from human iPSCs and somatic cells. In iCSCs, gene expression kinetics of the core pluripotency factor and the Myc-related
factor were pluripotent type, whereas the polycomb complex factor was somatic type. These findings indicate that
pluripotent tumorigenicity can be conferred on somatic cells through up-regulation of the core pluripotency and Myc-
related factors, prior to establishment of the iPSC molecular network by full reprogramming through down-regulation of the
polycomb complex factor.
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Introduction
Cancer stem cells (CSCs), which are subpopulations of tumor
cells, function in maintaining cancers through initiation and
propagation of perpetuating tumor growth [1]. CSCs are thought
to be key targets of cancer therapies, but the details of their genetic
and epigenetic signatures are unclear. As a gold standard to define
CSC properties, a serial transplantation assay based on the ability
to self-renew and generate tumors has been widely used [2]. A
crucial event in initiating cancers is activation of the self-renewal
machinery, which is normally limited to stem cells. Therefore, it is
likely that CSCs share several gene expression signatures detected
in pluripotent stem cells. In fact, pluripotent marker genes, Oct4
and Nanog, are expressed in some cancers [3,4], and oncogene Myc
is involved in the generation of many cancers [5].
Forced expression of a combination of transcriptional factors,
Oct4, Sox2, Klf4, and c-Myc (OSKM), can promote direct
reprogramming of human and mouse somatic cells into induced
pluripotent stem cells (iPSCs) [6,7]. In direct reprogramming, Oct4
and Sox2, which are core pluripotency factors, function as
regulators of developmental and transcription-associated processes
[8], Myc targets genes predominantly involved in cellular
metabolism, cell cycle, and protein synthesis pathways [9].
Furthermore, Myc functions to increase efficiency by regulating
the p53 pathway [10]. This evidence indicates that common
pathways could be used both in the acquisition of pluripotency and
tumorigenesis. In humans, CSC-like cells were transformed from
primary skin fibroblasts by the stable expression of hTERT, H-
RasV12, and SV40 LT and ST antigens [11]. In mice, CSCs were
generated from mouse induced pluripotent stem cells (iPSCs) by
culture with a conditioned medium of cancer cell lines, which was
a mimic of the carcinoma microenvironment [12]. Thus, global
change of the transcription signature through direct reprogram-
ming or alternative culture conditions could promote the trans-
formation to CSCs. In this context, it is possible that forced
expression of OSKM in somatic cells induces direct reprogram-
ming into CSCs. To address the molecular mechanisms involved
in embryonic stem (ES) cells and CSCs, three functionally different
gene sets, called the Core (core pluripotency factors), PRC
(polycomb repressive complex factors), and Myc (Myc-related
factors) modules, proposed recently were used for comparative
analyses of global gene activity between different types of cells [9].
Here, in order to address questions of whether human induced
cancer stem-like cells (iCSCs) can be generated by somatic
reprogramming through conventional OSKM viral induction,
and how human iCSCs, but not iPSCs, are generated, first we
isolated iCSCs from cell populations, which acquired the ability to
self-renew after forced expression of exogenous OSKM in human
somatic fibroblasts TIG1. iCSCs have the property of pluripotency
as verified by teratoma formation through serial transplantation to
immunodeficient mice. Notably, the gene expression signature
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demonstrated that iCSCs persist certain somatic cell memory even
after up-regulation of pluripotent marker genes through repro-
gramming. Our findings revealed that up-regulation of gene sets
for the Core and Myc modules is sufficient to confer the properties
of self-renewal and pluripotency, and sequential down-regulation
of gene sets for the PRC module is required to install the proper
iPSC signature on somatic cells. These findings demonstrate that
iCSCs and iPSCs share a reprogramming pathway from somatic
nuclei into pluripotent and self-renewable nuclei, and then diverge
to iCSCs or iPSCs.
Materials and Methods
Ethics statement
Experiments with mice were performed according to the
institutional guideline of Kyoto University, Japan. Our animal
experiments (W-3-6) are reviewed and permitted by the animal
research committee of Kyoto University, Japan.
Cell culture
Human fetal lung fibroblasts (TIG1) provided by the JCRB Cell
Bank were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Sigma-Aldrich, USA) containing 10% FBS, and were
infected with Oct4, Sox2, Klf4 and c-Myc retroviruses. At day 4
after infection, the cells were reseeded into a 10 cm culture dish on
feeder cells. At day 5 after infection, culture medium was changed
to iPSC medium (DMEM/Nutrient Mixture F-12 Ham (DMEM/
F12) (Sigma-Aldrich) supplemented with 20% of knockout serum
replacement (Invitrogen, USA), 10 ng/ml bFGF (Peprotech,
USA), L-glutamine, and non-essential amino acids and 2-
mercaptoethanol). Colonies, which could self-renew and expand,
were picked up and reseeded onto feeder cells around day 30. To
isolate human iPSCs and induced epithelial stem cells (iESCs),
each colony was picked up and reseeded into Matrigel-coated
dishes with mouse embryonic fibroblast (MEF)-conditioned iPSC
medium.
For embryoid body (EB) formation, small iESC aggregates were
formed by overnight hanging drop culture in MEF-conditioned
iPSC medium. Aggregates were grown in bacterial culture dishes
for 5–7 days, and then cultured in gelatin-coated dish with
DMEM containing 10% FBS.
For tumor-derived cell culture, tumors were cut into small
pieces, dissociated with collagenase, and plated on gelatin-coated
dishes with 10% FBS containing DMEM. Established iCSC lines
were maintained in gelatin-coated dish with DMEM/F12 (Wako,
Japan) supplemented with 15% FBS, 1000 U/ml LIF (Chemicon,
USA), L-glutamine, penicillin-streptomycin, sodium bicarbonate,
sodium pyruvate, and 2-mercaptoethanol through passage using
0.25% trypsin/EDTA.
RT-PCR
For RT-PCR analyses, total RNA of cultured cells was
extracted with TRIzol reagent (Invitrogen). cDNA was synthesized
from 1 mg total RNA with Superscript III (Invitrogen) using
random hexamers following the manufacturer’s instructions. All
PCR experiments were performed with the annealing temperature
at 57uC. Primer sequences used in this study are summarized in
Table S1.
Immunocytochemistry
Cultured cells were fixed with 4% PFA (paraformaldehyde)/
PBS (phosphate-buffered saline) for 10 minutes at room temper-
ature, washed with PBST (0.1% Triton X-100 in PBS), then pre-
treated with blocking solution (3% BSA and 2% skim milk
(DIFCO, USA) in PBST) at 4uC overnight. The cells were
incubated with primary antibodies; anti-OCT4 (1:50; Santa Cruz
Biotechnology, USA), anti-SOX2 (1:500; Abcam, UK) and anti-
NANOG (1:200; ReproCELL, Japan), anti-CDH1 (1:200; Ta-
KaRa, Japan), anti-SSEA4 (1:500; Hybridoma Bank, USA), and
anti-TRA-1-60 (1:500; Millipore, USA) antibodies at 4uC over-
night. They were then incubated with secondary antibodies; anti-
rabbit IgG or anti-mouse IgG conjugated with Alexa 488 (1:500;
Molecular Probes, USA) in blocking buffer for 1 hour at room
temperature. The cells were counterstained with DAPI (4,6-
diamidino-2-phenylindole) and mounted with a SlowFade light
antifade kit (Invitrogen).
Tumor formation
A cell suspension of 5.06105 iESCs or iCSCs in 200 ml DMEM
was subcutaneously injected into the inguinal region or trans-
planted into the kidney capsules of immunodeficient SCID mice
(CLEA, Japan). Tumors were surgically dissected out 5–7 weeks
after implantation, fixed with 4% paraformaldehyde in PBS and
embedded in paraffin. Sections 5 mm in thickness were stained
with hematoxylin and eosin.
Microarray and data processing
For microarray analyses, 1 mg total RNA was labeled according
to standard Affymetrix protocols and hybridized to the Affymetrix
human genome U133 Plus 2.0 Array (samples of human origin).
Raw data were normalized by the MAS 5.0 method using the
bioconductor package on R program (http://www.r-project.org/).
Heat maps of the gene expression profile for all genes in each cell
line were visualized by MeV program (http://www.tm4.org/mev/
). Hierarchical clusters were calculated by Pearson’s correlation
coefficient (r) and visualized by the pvclust package on R program.
For scatter plot analyses, raw data were normalized by Robust
Multichip Average (RMA). Scatter plots were visualized using the
bioconductor package on R program.
Results and Discussion
Isolation of iESCs and iCSCs
Human iPSCs were picked up as colonies about 30 days after
retroviral transduction of Oct4, Sox2, Klf4 and c-Myc into the
somatic fibroblasts TIG1, a cell line isolated from human fetal lung
(Fig. 1A). The efficiency of iPSC generation was less than 1%, and
the other populations of cells were differentially reprogrammed.
Some of the differentially reprogrammed somatic cells showed the
property of self-renewal formed colonies consisting of cells (iESCs)
with epithelial cell morphology in MEF-conditioned iPSC medium
(Fig. 1A). iESCs were maintained with epithelial cell morphology
for around 10 passages, since were prone to differentiate
(Fig. S1A). Therefore, to analyze the differentiation potential of
iESCs, EB formation was induced by suspension culture (Fig. 1B).
Successfully formed iESC EBs showing pluripotency as analyzed
by RT-PCR (Fig. 2A) were attached on the bottom to culture
dishes to isolate self-renewal stem cells. Consequently, the first (1st)
iCSC lines isolated by picking cell clumps of expanded EBs in
three independent experiments were stably maintained for more
than 20 passages, or re-plated from frozen-stored cells (Fig. 1B).
To verify the identity of the 1st iCSCs, the second (2nd) iCSCs
were isolated from tumors generated by serial transplantation with
injection of the 1st iCSCs into the inguinal regions of immuno-
deficient SCID mice in two independent experiments (Fig. 1C).
The 2nd iCSCs resembling the 1st iCSCs were stably maintained
with features of epithelial cell morphology and robust cell growth
for more than 20 passages (Fig. 1C). Next, to explore the
Reprogramming into Cancer Stem Cell
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pluripotency of iESCs, 1st iCSCs, and 2nd CSCs, the cells were
transplanted into kidney capsules or inguinal regions of SCID
mice. Formation of teratomas containing ecotoderm, mesoderm,
and endoderm derivatives was detected with hematoxylin and
eosin staining at high frequency in all cell types (Fig. 2B),
indicating that the three cell types were stem cells acquiring
pluripotency, despite having epithelial cell morphology.
Gene expression profile of iESCs and iCSCs
To examine the gene expression in iESCs and iCSCs, global
gene expression profiles detected by gene expression microarray
analyses were compared. Among TIG1, iESCs, 1st iCSCs, and
iPSCs, iESCs and iCSCs closely resemble each other. Interest-
ingly, iESCs and iCSCs were more similar to somatic cells, and
TIG1 rather than human pluripotent cells (iPSCs and ES cells),
even with the consistent high expression of the exogenous Oct4,
Sox2, Klf4, and c-Myc (Fig. S2 and Fig. 3A and 3B). Consistent with
this, data on heat map analyses demonstrated that iESCs
maintained an intermediate state between somatic fibroblasts
TIG1 and pluripotent iPSCs (Fig. 3A). In more detail, scatter plot
analyses showed that, in iESCs, expression of somatic marker
genes MAB21L1 and NR2F2 was high to iPSCs, whereas
expression of pluripotent marker genes TDGF1, NANOG, ZIC2,
and TPD52 similar to iPSCs (Fig. 3A). Similar to iESCs, 1st iCSCs
were characterized by expression of some somatic marker genes.
RT-PCR analyses verified that the expression of endogenous
pluripotent marker genes, OCT4, SOX2, NANOG, REX1, LIN28,
was obviously low, while somatic marker genes, EMP1, PPARc,
Figure 1. Generation of iPSC, induced epithelial stem cell (iESC), and induced cancer stem-like cell (iCSC) lines. (A) Generation of iPSCs
and iESCs through direct reprogramming of primary fetal fibroblasts (TIG1). (B) Generation of the first (1st) iCSCs by picking a cell clump (yellow circle)
through iESCs-derived embryoid bodies (iESC EB) formation. (C) Generation of the second (2nd) iCSCs by picking a cell clump (yellow circle) through
serial transplantation of the 1st iCSCs.
doi:10.1371/journal.pone.0048699.g001
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FOXF2, and NR2F2 were highly expressed in the 1st and 2nd
iCSCs (Fig. 3A and 3B), indicating that epigenetic reprogramming
went halfway to erasing the somatic memory and establishing
a pluripotent transcription network. Low expression of NANOG
was detected by immunocytochemistry in the 1st and 2nd iCSCs,
while high expression of endogenous OCT4/exogenous Oct4 and
endogenous SOX2/exogenous Sox2 was detected (Fig. 3C).
Immunocytochemistry analyses demonstrated that pluripotent
markers CDH1 and SSEA4 were weakly expressed in iESCs
and iCSCs, while highly in iPSCs. Furthermore, expression of
TRA-1-60 was detected in iPSCs, but not iESCs and iCSCs
(Fig. S3). Collectively, iESCs and iCSCs retained a cellular state
between TIG1 and iPSCs.
Acquisision of pluripotency prior to establishment of
iPSC identity
In the process of reprogramming somatic cells into iPSCs, cells
progressively change their expression patterns and morphology.
Thus, to compare gene expression profiles of different types of
reprogramming cells, an integrated analysis system for expression
profiles, in terms of the kinetics of modules, is required. Three ES
cell modules, Core, PRC, and Myc (CPM), which are functionally
separable, have been defined [9]. The Core module includes
known factors in core regulatory circuitry, such as NANOG, OCT4,
SOX2, TCF3, and REX1. The PRC module includes gene
generally repressed in ES cells, including HOX cluster genes.
The Myc module is composed of genes that are common targets of
seven factors, MYC, MAX, NMYC, DMAP1, E2F1, E2F4, and
ZFX. In addition, the ES cell-like module was defined to
distinguish among ES cells, adult tissue stem cells, and human
cancers [13]. Here, we demonstrate data with CPM modules,
since analysis with data of the ES cell-like module was comparable
to data of the Core module of CPM modules, which included
pluripotent marker genes.
To reprogram TIG1 into iESCs, up-regulation of the Core and
Myc modules was required (Fig. 4 and Fig. S4). iESCs and iCSCs
were characterized by the high activity of the PRC and Myc
modules, while the Core module was high in iESCs and low in
iCSCs. It was crucial to impose a barrier for erasing somatic
memory that the PRC module retained high activity in all TIG1,
iESCs, and iCSCs as shown by FOXF2 and NR2F2 (Fig. 3A). To
be fully reprogrammed into iPSCs from TIG1, induction of the
down-regulation of the PRC module was necessary (Fig. 4 and
Fig. S4), indicating that completion of the establishment of the
iPSC-transcriptional network is associated with down-regulation of
the PRC module.
Stable cell lines, TIG1, iCSC, and iPSC, were characterized by
the reciprocal activity of the Core and PRC modules, while
unstable iESCs showed simultaneous up-regulation of the two
modules, suggesting that genes categorized into the two modules
functioned competitively in reprogramming. Notably, acquisition
of self-renewal and pluripotency was linked with up-regulation of
the Core and Myc, but not PRC, modules (Fig. 4). These data
indicated that the property of self-renewal and pluripotency could
be conferred on somatic nuclei prior to full reprogramming into
iPSCs. The finding that a certain cell population of iESCs was
reprogrammed into iPSCs spontaneously supported this concept
(Fig. S1B). The criteria of self-renewal and pluripotency are widely
used for defining human iPSCs. However, the property of self-
renewal and pluripotency can be conferred on a variety of cell
Figure 2. Pluripotent tumorigenicity of iESCs and iCSCs. (A) Expression of exogenous, pluripotent marker, and lineage marker genes in
embryoid bodies (EBs) formed with iESCs and iPSCs by RT-PCR analyses. (B) Paraffin sections of teratomas, which were generated by iESCs, 1st iCSCs,
and 2nd iCSCs implantation, were stained with hematoxylin and eosin. NE, neuroepithelium (ectoderm); CA, cartilage (ectoderm); MU, muscle
(mesoderm); RE, respiratory epithelium (endoderm).
doi:10.1371/journal.pone.0048699.g002
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types through reprogramming more than we expected, and are
necessary, but not sufficient, for defining iPSC identity.
To reprogram somatic cells to iCSCs, up-regulation of the Myc
module is a key event. Promoter regions bound by MYC are
linked with histone H3 lysin4 trimethylation (H3K3me3), which is
positively correlated with the formation of open chromatin, and
gene activation as an epigenetic signature [9]. Furthermore, MYC
interacts with histone acetyltransferases, which are associated with
transcription activation complexes [14]. The Myc module
facilitates cell metabolism by activating general genes. Genes in
the Core module are also up-regulated through somatic repro-
gramming to iCSCs. OCT4, SOX2, and NANOG, which are key
Core module players, repress developmentally important home-
odomain proteins through co-occupation of their target genes,
while promote self-renewal and pluripotency by positive regulation
of genes encoding components of key signaling pathways [15].
Taking these into consideration, the Core and Myc modules play
a role in conferring the features of self-renewal and pluripotency
on somatic nuclei, whereas continuously high activity of the PRC
module in TIG1, iESCs, and iCSCs impedes the resetting of the
somatic memory of some developmentally important home-
odomain proteins (Fig. 4). The polycomb repressive complexes,
Figure 3. Global expression analysis of iESCs and iCSCs. (A) Gene expression microarray analysis among TIG1, iESCs, iCSCs, and iPSCs. Heat
map (upper panel) shows differentially expressed genes of somatic and pluripotent genes. Scatter plots (lower panel) show comparison of global
gene expression profiles. Yellow; genes in the Core module, Blue; genes in the PRC module, and Red; gene in the Myc module. (B) Expression analysis
of pluripotent marker genes, somatic cell marker genes, and exogenous genes in TIG1, iPSCs, iESCs, 1st iCSCs, and 2nd iCSCs by RT-PCR analyses. (C)
Expression of pluripotent marker proteins (Green) in iESCs, 1st iCSCs, and 2nd iCSCs by immunocytochemistry. Cell nuclei are counterstained blue
with DAPI (Blue). Exo-, exogenous; Endo-, endogenous.
doi:10.1371/journal.pone.0048699.g003
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especially polycomb repressive complex 2 containing Ezh2, Eed,
and Suz12, are crucial repressors of genes in association with
H3K27me3 [16]. In order to reset the somatic memory of genes
with a homeodomain in iESCs and iCSCs and over-write the ES
cell-like epigenetic signature in the reprogrammed nuclei of iESCs,
the activity of the PRC module should be reduced continuously or
transiently. Relatively reduced activity of the PRC module may be
a key event for reprogramming somatic cells to iPSCs. It is
speculated that lack of H3K27me3 plays important roles in
promoting reprogramming from pre-iPSCs to iPSCs in the late
phase of reprogramming [17]. The fate of somatic cells, whether
they are reprogrammed to iCSCs or iPSCs, could be determined
by activity of the PRC module, after acquiring the capability of
self-renewal and pluripotency (Fig. 4).
Supporting Information
Figure S1 Spontaneous differentiation of iESCs and conversion
into iPSCs. (A) Differentiation of iESCs after long-term culture. (B)
Conventional iPSCs (right panel) were generated from a small
colony (yellow circle in left panel) appearing in iESC culture at
high cell density.
(TIF)
Figure S2 Global gene expression analysis of iESCs and iCSCs.
Comparative analysis of global gene expression profile in iPSC,
human embryonic stem (ES) cell, iESC, 1st iCSC, and TIG1 lines
by gene expression microarray assay.
(TIF)
Figure S3 Expression of pluripotent marker proteins in iESCs
and iCSCs. Expression of marker cell surface proteins, CDH1,
SSEA4, and TRA-1-60 was detected as green fluorescence, while
cell nuclei were as blue with DAPI.
(TIF)
Figure S4 Average gene expression values (log2) of CPM
modules in in somatic cells and pluripotent stem cells.
(TIF)
Table S1 Primers for RT-PCR analyses.
(DOC)
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